Tracking Emergence of New Motor and Non-Motor Symptoms Using the MDS-UPDRS: A Novel Outcome Measure for Early Parkinson’s Disease?

BACKGROUND: Summary scores of current clinical rating scales do not appear sensitive enough to quantify changes in disease progression in early Parkinson’s disease (PD) clinical trials. An alternate approach might be to track the appearance of new or emergent symptoms (ES) over time as a measure of...

Descripción completa

Detalles Bibliográficos
Autores principales: Tosin, Michelle H.S., Simuni, Tanya, Stebbins, Glenn T., Cedarbaum, Jesse M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2022
Materias:
Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198734/
https://www.ncbi.nlm.nih.gov/pubmed/35466955
http://dx.doi.org/10.3233/JPD-223170

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198734/
https://www.ncbi.nlm.nih.gov/pubmed/35466955
http://dx.doi.org/10.3233/JPD-223170

Ejemplares similares